多家A股上市公司2025年业绩大幅预增。 深南电A（000037）1月22日晚间发布2025年度业绩预告，预计归属于上市公司股东的净利润为1.50亿— 1.80亿元，比上年同期增长584.66%—721.59%。报告期内，公司控股子公司完成土地收储及发电机组设 备等资产转让，确认资产处置损益约2.8亿—2.9亿元；同时，报告期内，公司聚焦主业提质增效，强化 经营管理，主营业务经营业绩稳步提升。 | | | 立 秋 八 八 | | --- | --- | --- | | 项目 | 本报告期 | 上年同期 | | 归属于上市 公司股东的 | 盈利:15,000 万元—18,000 万元 | 盈利: 2,190.88 万 | | 净利润 | 比上年同期增长:584.66%- | 元 | | | 721. 59% | | | 扣除非经常 性损益后的 | 亏损:7,000万元-8,600万元 | 亏损:8,750.81 万 | | 净利润 | | 元 | | 基本每股收 | 盈利:0.2489元/股-0.2986元/ | 盈利:0.0363元/股 | | 益 | 股 | | 闰土股份（002440）发布2025年度业绩 ...

多家A股上市公司2025年业绩大幅预增。 深南电A（000037）1月22日晚间发布2025年度业绩预告，预计归属于上市公司股东的净利润为1.50亿— 1.80亿元，比上年同期增长584.66%—721.59%。报告期内，公司控股子公司完成土地收储及发电机组设 备等资产转让，确认资产处置损益约2.8亿—2.9亿元；同时，报告期内，公司聚焦主业提质增效，强化 经营管理，主营业务经营业绩稳步提升。 | | | 立 17 1 | | --- | --- | --- | | 项目 | 本报告期 | 上年同期 | | 归属于上市 公司股东的 | 盈利:15,000 万元—18,000 万元 | 盈利: 2,190.88 万 | | 净利润 | 比上年同期增长:584.66% | 元 | | | 721. 59% | | | 扣除非经常 性损益后的 | 亏损:7,000万元-8,600万元 | 亏损:8,750.81 万 | | 净利润 | | 元 | | 基本每股收 | 盈利:0.2489元/股-0.2986元/ | 盈利:0.0363元/股 | | 益 | 股 | | | 项目 | 本报告期 | 上年同期 | | - ...

多家A股上市公司2025年业绩大幅预增。 深南电A(000037)1月22日晚间发布2025年度业绩预告，预计归属于上市公司股东的净利润为1.50亿— 1.80亿元，比上年同期增长584.66%—721.59%。报告期内，公司控股子公司完成土地收储及发电机组设 备等资产转让，确认资产处置损益约2.8亿—2.9亿元；同时，报告期内，公司聚焦主业提质增效，强化 经营管理，主营业务经营业绩稳步提升。 | | | 立 创 个: 八人 | | --- | --- | --- | | 项目 | 本报告期 | 上年同期 | | 归属于上市 公司股东的 | 盈利:15,000 万元—18,000 万元 | 盈利: 2,190.88 万 | | 净利润 | 比上年同期增长:584.66% | 元 | | | 721. 59% | | | 扣除非经常 性损益后的 | 亏损:7,000万元-8,600万元 | 亏损:8,750.81 万 | | 净利润 | | 元 | | 基本每股收 | 盈利:0.2489元/股-0.2986元/ | 盈利:0.0363 元/股 | | 益 | 股 | | | 项目 | 本报告期 | 上年同期 | ...

Core Viewpoint - Multiple A-share listed companies are expected to significantly increase their performance in 2025, with notable growth in net profits compared to the previous year [1][2]. Group 1: Company Performance Forecasts - ShenNan Electric A (000037) anticipates a net profit attributable to shareholders of 150 million to 180 million yuan, representing a growth of 584.66% to 721.59% compared to the previous year [1][3]. - LunTuo Co. (002440) expects a net profit of 600 million to 700 million yuan, an increase of 181.05% to 227.89% year-on-year, driven by improved profits from active dyes and basic chemicals [1][4]. - Qingsong Co. (300132) forecasts a net profit of 130 million to 165 million yuan, reflecting a growth of 137.73% to 201.74% year-on-year, supported by a recovery in the domestic cosmetics market [1][5]. - TianHe Co. (002999) projects a net profit of 41 million to 60 million yuan, indicating an increase of 84.35% to 169.78% compared to the previous year, despite challenges in the agricultural market [1][6]. Group 2: Key Financial Metrics - ShenNan Electric A's basic earnings per share are expected to be between 0.2489 yuan and 0.2986 yuan, compared to 0.0363 yuan in the previous year [3]. - LunTuo Co. anticipates basic earnings per share of 0.53 yuan to 0.62 yuan, up from 0.19 yuan year-on-year [4]. - Qingsong Co. expects basic earnings per share of 0.12 yuan to 0.17 yuan, compared to 0.06 yuan in the previous year [5]. - TianHe Co. projects basic earnings per share of 0.12 yuan to 0.17 yuan, an increase from 0.06 yuan year-on-year [6].

青松股份（300132）1月22日发布2025年业绩预增公告，预计实现净利润为1.30亿元~1.65亿元，净利润 同比增长137.73%~201.74%。 资金面上，该股今日主力资金净流入486.72万元，近5日资金净流出493.45万元。 从机构评级来看，近一个月该股被1家机构评级买入。预计目标价最高的是广发证券，1月19日广发证券 发布的研报给予公司目标价位10.50元。（数据宝） （文章来源：证券时报网） 证券时报·数据宝统计显示，青松股份今日收于9.28元，上涨1.53%，日换手率为4.40%，成交额为2.06亿 元，近5日上涨8.03%。通过对2025年业绩预增50%以上的个股走势进行统计发现，预告发布后当日股价 上涨的占比63.36%，股价发布当日股价涨停的有9家。预告发布后5日股价上涨的占比75.57%。 ...

Group 1 - ShenNan Electric A expects a net profit increase of 584.66%-721.59% year-on-year for 2025 [1] - Te Yi Pharmaceutical anticipates a net profit increase of 241.55%-339.13% year-on-year for 2025 [1] - RunTu Co. forecasts a net profit increase of 181.05%-227.89% year-on-year for 2025 [1] - QingSong Co. projects a net profit increase of 137.73%-201.74% year-on-year for 2025 [1] - RuiSheng Intelligent expects a net profit increase of 112.00%-139.99% year-on-year for 2025 [1] - JianKai Technology anticipates a net profit increase of 101.09%-121.20% year-on-year for 2025 [1] - XingQi Eye Medicine forecasts a net profit increase of 95.82%-121.56% year-on-year for 2025 [1] - RuiChuang MicroNano expects a net profit increase of approximately 93% year-on-year for 2025 [1] - TianHe Co. projects a net profit increase of 84.35%-169.78% year-on-year for 2025 [1] - ZhongYuan Co. anticipates a net profit increase of 80%-105% year-on-year for 2025 [1] - YiDao Information expects a net profit increase of 76.04%-128.85% year-on-year for 2025 [1] - ShengDa Bio forecasts a net profit increase of 69.93%-120.90% year-on-year for 2025 [1] - HuaRui Precision anticipates a net profit increase of 68.29%-86.99% year-on-year for 2025 [1] - FangZheng Technology expects a net profit increase of 67.06%-98.14% year-on-year for 2025 [1] - JinLing Hotel projects a net profit increase of 65.37%-90.93% year-on-year for 2025 [1] - QiangYi Co. anticipates a net profit increase of 57.87%-71.17% year-on-year for 2025 [1] - LangBo Technology expects a net profit increase of 57.58%-66.53% year-on-year for 2025 [1] - HuaFeng Measurement and Control forecasts a net profit increase of 46%-78% year-on-year for 2025 [1] - Zhaoyi Innovation anticipates a net profit increase of approximately 46% year-on-year for 2025 [1] - JieChang Drive expects a net profit increase of 40%-55% year-on-year for 2025 [1] - ShengYuan Environmental Protection projects a net profit increase of 31.79%-59.24% year-on-year for 2025 [1] - GuangHa Communication anticipates a net profit increase of 21.83%-31.31% year-on-year for 2025 [1] - MaiHe Co. expects a net profit increase of 19.58%-54.76% year-on-year for 2025 [1] Group 2 - YiLing Pharmaceutical expects a net profit of 1.2 billion to 1.3 billion yuan for 2025, turning profitable year-on-year [1] - LiYade anticipates a net profit of 300 million to 380 million yuan for 2025, turning profitable year-on-year [1] - SiRuiPu expects a net profit of 165 million to 184 million yuan for 2025, turning profitable year-on-year [1] - DaMing City anticipates a net profit of 140 million to 165 million yuan for 2025, turning profitable year-on-year [1] - DaHeng Technology expects a net profit of 106 million yuan for 2025, turning profitable year-on-year [1] - GuangHua Technology projects a net profit of 85 million to 120 million yuan for 2025, turning profitable year-on-year [1] - BoTeng Co. expects a net profit of 80 million to 105 million yuan for 2025, turning profitable year-on-year [2] - ZhongBing HongJian anticipates a net profit of 34 million to 46 million yuan for 2025, turning profitable year-on-year [2]

北京商报讯1月22日，青松股份发布业绩预告称，预计2025年归属于上市公司股东的净利润1.3亿元-1.65 亿元，同比增长137.73%-201.74%。业绩变动主要原因是，国内化妆品行业整体消费呈稳步复苏态势， 公司客户订单需求有所增长，带动公司营业收入同比增长；报告期内公司实现营业收入约为22.18亿 元，同比2024年上升约14.34%；报告期内，公司有效执行"聚焦客户、聚焦产品"的两个聚焦战略，通过 主动筛选优质客户、聚焦高质量订单，在客户管理、产品研发、市场开发、成本控制、产品结构调整和 人力资源管理等方面深耕细作，有效提升了产品综合竞争力和盈利水平。 （文章来源：北京商报） ...

Major Announcements - Zhaoyi Innovation plans to use 500 million CNY of A-share fundraising to increase capital in its wholly-owned subsidiaries for the implementation of the DRAM project [1] - Haiguang Information's mid-2025 profit distribution plan includes a cash dividend of 0.09 CNY per share, totaling 209 million CNY [2] - *ST Biology has terminated the major asset restructuring plan to acquire 51% of Hunan Huize Biomedical Technology Co., Ltd. [3] - Fosun Pharma intends to spin off its subsidiary Fosun Antigen for independent listing on the Hong Kong Stock Exchange [4] - Jingchen Co. has set the inquiry transfer price at 82.85 CNY per share for the transfer of 13.1 million shares [5] Performance Forecasts - Zhaoyi Innovation expects a net profit of approximately 1.61 billion CNY for 2025, a year-on-year increase of about 46% [9] - Longying Precision anticipates a net profit decrease of 17.70% to 29.36% for 2025, estimating between 545 million CNY and 635 million CNY [9] - Ruichuang Micro-Nano forecasts a net profit of around 1.1 billion CNY for 2025, representing a 93% increase [10] - Nanjing Bank projects a net profit of 21.81 billion CNY for 2025, an 8.08% increase year-on-year [11] - Zhongyuan Co. expects a net profit increase of 80% to 105% for 2025, estimating between 139 million CNY and 158 million CNY [12] - Qiangyi Co. anticipates a net profit increase of 57.87% to 71.17% for 2025, estimating between 368 million CNY and 399 million CNY [13] - Liard expects a net profit of 300 million CNY to 380 million CNY for 2025, turning from a loss of 889 million CNY in the previous year [14] - Daheng Technology forecasts a net profit of approximately 106 million CNY for 2025, also turning from a loss [16] - Dongfeng Co. anticipates a net loss of 390 million CNY to 480 million CNY for 2025 [17] - Qing Song Co. expects a net profit increase of 137.73% to 201.74% for 2025, estimating between 130 million CNY and 165 million CNY [18] - SIRUI Co. forecasts a net profit of 165 million CNY to 184 million CNY for 2025, turning from a loss [19] - Shengmei Shanghai expects a revenue increase of 18.91% to 22.47% for 2025, estimating between 6.68 billion CNY and 6.88 billion CNY [20] - Yijun Co. anticipates a net loss of 11 million CNY to 14 million CNY for 2025 [21] - Saint Yuan Environmental Protection expects a net profit increase of 31.79% to 59.24% for 2025, estimating between 240 million CNY and 290 million CNY [22] - Lijun Co. forecasts a net profit decrease of 45.05% to 60.03% for 2025, estimating between 4.8 million CNY and 6.6 million CNY [23] - Xingqi Eye Medicine expects a net profit increase of 95.82% to 121.56% for 2025, estimating between 662 million CNY and 749 million CNY [25] - Beidou Star expects a net loss of 230 million CNY to 290 million CNY for 2025, reducing losses compared to the previous year [26] - Yiling Pharmaceutical anticipates a net profit of 1.2 billion CNY to 1.3 billion CNY for 2025, turning from a loss of 725 million CNY [27] - Zhijiang Bio forecasts a net loss of 32 million CNY to 47 million CNY for 2025, reducing losses compared to the previous year [28] - Yema Battery expects a net profit decrease of 58% to 70% for 2025, estimating between 45.83 million CNY and 64.17 million CNY [29] - Yunmei Energy anticipates a net loss of 410 million CNY to 470 million CNY for 2025 [30] - Yingfang Micro expects a net loss of 69 million CNY to 97 million CNY for 2025 [31] - Guanghua Technology forecasts a net profit of 85 million CNY to 120 million CNY for 2025, turning from a loss [33] Share Buybacks - Hengyi Petrochemical plans to repurchase shares worth 500 million CNY to 1 billion CNY [34] - Yunyi Electric plans to repurchase shares worth 100 million CNY to 150 million CNY [34] - Xidun Pharmaceutical plans to repurchase shares worth 25 million CNY to 50 million CNY [35]

中证智能财讯青松股份（300132）1月22日晚间披露2025年度业绩预告，预计2025年实现营业收入22.18亿元，同比增长14.34%；归母净利润1.3亿元至1.65亿 元，同比增长137.73%-201.74%；扣非净利润预计9600万元至1.31亿元，同比增长73.29%-136.47%。以1月22日收盘价计算，青松股份目前市盈率（TTM）约 为29.05倍-36.88倍，市净率（LF）约3.4倍，市销率（TTM）约2.16倍。 以本次披露业绩预告均值计算，公司近年市盈率（TTM）图如下所示： 制图数据来自恒生聚源数据库 近年来市盈率变化情况（倍） 120 @ 90 60 30 20x41——23x28——26x32 0 2d al 18.09 -30 -60 68.04 -90 2021-12-37 2020-12-37 ' 2022-72-37 -06-30 1-06-30 -2-06-30 +-06-30 *-723, 2n- -○- 公司 -○- 行业均值 100 ହ 90 80 70 60 50 40 30 66 20 16:68 10 0 2027-12-37 I 2022-12-37 1 ...

青松股份（300132）(300132.SZ)披露2025年度业绩预告，公司预计归属于上市公司股东的净利润1.3亿 元至1.65亿元，同比增长137.73%至201.74%;扣除非经常性损益后的净利润9600万元至1.31亿元，同比增 长73.29%至136.47%。 ...